Baricitinib versus ritlecitinib for severe alopecia areata: A 24-week real-world study.

Cedirian S, Martelli G, Pampaloni F, Rapparini L, Quadrelli F, Bruni F, Ala L, Bortone G, Acri MC, Rossi A, Pellacani G, Lacarrubba F, Dall'Oglio F, Micali G, Foggia L, Cantelli M, D'Elia C, Nappa P, Diluvio L, Matteini E, Bianchi L, Naldi L, Bolzon A, Peris K, Caldarola G, Pinto LM, Girolomoni G, Marangoni F, Bellinato F, Gisondi P, Silvi G, Prignano F, Pimpinelli N, Tomasini C, Barruscotti S, Simonetti O, De Simoni E, Ambrogio F, Foti C, Boccaletti V, Romanò C, Fraghì A, Marzano AV, Mattioli MA, Ferrucci S, Sechi A, Valtellini L, Barbareschi M, Gallo G, Ortoncelli M, Ribero S, Quaglino P, Di Corteranzo IG, Balestri R, Pagliarello C, Caro RDC, Zalaudek I, Vagnozzi E, Fargnoli MC, Caponio C, Rubegni P, Cinotti E, Trovato E, Romanelli M, Dini V, Margiotta FM, Feliciani C, Satolli F, Del Giudice MBF, Atzori L, Sanna S, Lembo S, Raimondo A, Magnano M, Argenziano G, Babino G, Fulgione E, Balato A, Rongioletti F, Pesce N, Guida S, Bigotto GD, Guglielmo A, Schettini N, Borghi A, Gargiulo L, Vignoli C, Narcisi A, Pezzolo E, Caroppo F, Fortina AB, Megna A, Filippeschi C, Oranges T, Tronconi G, Patrignani A, Piraccini BM, Starace M

Open source

DOI: 10.1111/jdv.70698
Published: 2026 Aug 31
Container: Journal of the European Academy of Dermatology and Venereology : JEADV
Publisher: Not recorded
Open access: no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1111/jdv.70698,
  title = {Baricitinib versus ritlecitinib for severe alopecia areata: A 24-week real-world study.},
  author = {Cedirian S and Martelli G and Pampaloni F and Rapparini L and Quadrelli F and Bruni F and Ala L and Bortone G and Acri MC and Rossi A and Pellacani G and Lacarrubba F and Dall'Oglio F and Micali G and Foggia L and Cantelli M and D'Elia C and Nappa P and Diluvio L and Matteini E and Bianchi L and Naldi L and Bolzon A and Peris K and Caldarola G and Pinto LM and Girolomoni G and Marangoni F and Bellinato F and Gisondi P and Silvi G and Prignano F and Pimpinelli N and Tomasini C and Barruscotti S and Simonetti O and De Simoni E and Ambrogio F and Foti C and Boccaletti V and Romanò C and Fraghì A and Marzano AV and Mattioli MA and Ferrucci S and Sechi A and Valtellini L and Barbareschi M and Gallo G and Ortoncelli M and Ribero S and Quaglino P and Di Corteranzo IG and Balestri R and Pagliarello C and Caro RDC and Zalaudek I and Vagnozzi E and Fargnoli MC and Caponio C and Rubegni P and Cinotti E and Trovato E and Romanelli M and Dini V and Margiotta FM and Feliciani C and Satolli F and Del Giudice MBF and Atzori L and Sanna S and Lembo S and Raimondo A and Magnano M and Argenziano G and Babino G and Fulgione E and Balato A and Rongioletti F and Pesce N and Guida S and Bigotto GD and Guglielmo A and Schettini N and Borghi A and Gargiulo L and Vignoli C and Narcisi A and Pezzolo E and Caroppo F and Fortina AB and Megna A and Filippeschi C and Oranges T and Tronconi G and Patrignani A and Piraccini BM and Starace M},
  year = {2026},
  journal = {Journal of the European Academy of Dermatology and Venereology : JEADV},
  doi = {10.1111/jdv.70698},
  url = {https://doi.org/10.1111/jdv.70698}
}

RIS

TY  - JOUR
TI  - Baricitinib versus ritlecitinib for severe alopecia areata: A 24-week real-world study.
AU  - Cedirian S
AU  - Martelli G
AU  - Pampaloni F
AU  - Rapparini L
AU  - Quadrelli F
AU  - Bruni F
AU  - Ala L
AU  - Bortone G
AU  - Acri MC
AU  - Rossi A
AU  - Pellacani G
AU  - Lacarrubba F
AU  - Dall'Oglio F
AU  - Micali G
AU  - Foggia L
AU  - Cantelli M
AU  - D'Elia C
AU  - Nappa P
AU  - Diluvio L
AU  - Matteini E
AU  - Bianchi L
AU  - Naldi L
AU  - Bolzon A
AU  - Peris K
AU  - Caldarola G
AU  - Pinto LM
AU  - Girolomoni G
AU  - Marangoni F
AU  - Bellinato F
AU  - Gisondi P
AU  - Silvi G
AU  - Prignano F
AU  - Pimpinelli N
AU  - Tomasini C
AU  - Barruscotti S
AU  - Simonetti O
AU  - De Simoni E
AU  - Ambrogio F
AU  - Foti C
AU  - Boccaletti V
AU  - Romanò C
AU  - Fraghì A
AU  - Marzano AV
AU  - Mattioli MA
AU  - Ferrucci S
AU  - Sechi A
AU  - Valtellini L
AU  - Barbareschi M
AU  - Gallo G
AU  - Ortoncelli M
AU  - Ribero S
AU  - Quaglino P
AU  - Di Corteranzo IG
AU  - Balestri R
AU  - Pagliarello C
AU  - Caro RDC
AU  - Zalaudek I
AU  - Vagnozzi E
AU  - Fargnoli MC
AU  - Caponio C
AU  - Rubegni P
AU  - Cinotti E
AU  - Trovato E
AU  - Romanelli M
AU  - Dini V
AU  - Margiotta FM
AU  - Feliciani C
AU  - Satolli F
AU  - Del Giudice MBF
AU  - Atzori L
AU  - Sanna S
AU  - Lembo S
AU  - Raimondo A
AU  - Magnano M
AU  - Argenziano G
AU  - Babino G
AU  - Fulgione E
AU  - Balato A
AU  - Rongioletti F
AU  - Pesce N
AU  - Guida S
AU  - Bigotto GD
AU  - Guglielmo A
AU  - Schettini N
AU  - Borghi A
AU  - Gargiulo L
AU  - Vignoli C
AU  - Narcisi A
AU  - Pezzolo E
AU  - Caroppo F
AU  - Fortina AB
AU  - Megna A
AU  - Filippeschi C
AU  - Oranges T
AU  - Tronconi G
AU  - Patrignani A
AU  - Piraccini BM
AU  - Starace M
PY  - 2026
JO  - Journal of the European Academy of Dermatology and Venereology : JEADV
DO  - 10.1111/jdv.70698
UR  - https://doi.org/10.1111/jdv.70698
ER  -

APA

S, C., G, M., F, P., L, R., F, Q., F, B., L, A., G, B., MC, A., A, R., G, P., F, L., F, D., G, M., L, F., M, C., C, D., P, N., L, D., E, M., L, B., L, N., A, B., K, P., G, C., LM, P., G, G., F, M., F, B., P, G., G, S., F, P., N, P., C, T., S, B., O, S., E, D. S., F, A., C, F., V, B., C, R., A, F., AV, M., MA, M., S, F., A, S., L, V., M, B., G, G., M, O., S, R., P, Q., IG, D. C., R, B., C, P., RDC, C., I, Z., E, V., MC, F., C, C., P, R., E, C., E, T., M, R., V, D., FM, M., C, F., F, S., MBF, D. G., L, A., S, S., S, L., A, R., M, M., G, A., G, B., E, F., A, B., F, R., N, P., S, G., GD, B., A, G., N, S., A, B., L, G., C, V., A, N., E, P., F, C., AB, F., A, M., C, F., T, O., G, T., A, P., BM, P., & M, S. (2026). Baricitinib versus ritlecitinib for severe alopecia areata: A 24-week real-world study.. Journal of the European Academy of Dermatology and Venereology : JEADV. https://doi.org/10.1111/jdv.70698

Source records

pubmed · retrieved 2026-09-26T06:22:29.795Z
europe-pmc · retrieved 2026-09-26T06:22:29.819Z